PACIFIC BIOSCIENCES OF CALIF (PACB)
US69404D1081 - Common Stock
ChartMill assigns a Buy % Consensus number of 76% to PACB. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 2.92. This target is 62.37% above the current price.
PACB was analyzed by 21 analysts. The buy percentage consensus is at 76. So analysts seem to be have mildly positive about PACB.
In the previous month the buy percentage consensus was at a similar level.
PACB was analyzed by 21 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-11-11 | ScotiaBank | Maintains | Sector Outperform -> Sector Outperform |
| 2024-11-11 | UBS | Downgrade | Buy -> Neutral |
| 2024-11-11 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2024-08-28 | ScotiaBank | Maintains | Sector Outperform -> Sector Outperform |
| 2024-08-12 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2024-08-08 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-08-08 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-06-03 | Jefferies | Initiate | Buy |
| 2024-05-15 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2024-05-13 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2024-05-10 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2024-04-22 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2024-04-19 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2024-04-18 | Bernstein | Maintains | Outperform -> Outperform |
| 2024-04-18 | ScotiaBank | Maintains | Sector Outperform -> Sector Outperform |
| 2024-04-18 | Goldman Sachs | Downgrade | Buy -> Neutral |
| 2024-04-17 | TD Cowen | Maintains | Buy -> Buy |
| 2024-04-10 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2024-04-10 | Goldman Sachs | Maintains | Buy -> Buy |
| 2024-02-16 | UBS | Maintains | Buy -> Buy |
| 2023-12-14 | Guggenheim | Initiate | Neutral |
| 2023-12-14 | Stephens & Co. | Initiate | Overweight |
| 2023-12-13 | Wolfe Research | Initiate | Peer Perform |
| 2023-11-17 | UBS | Upgrade | Neutral -> Buy |
| 2023-11-06 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2023-10-31 | Cantor Fitzgerald | Upgrade | Neutral -> Overweight |
| 2023-10-31 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2023-10-24 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-10-16 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2023-09-29 | Barclays | Maintains | Equal-Weight -> Equal-Weight |